Medically reviewed by Renee Nilan, MD Key Takeaways COVID arm rash is a mild reaction that usually appears a week after the ...

Share on Pinterest What does the ‘world-first’ vaccine designed by artificial intelligence mean for public health? Image credit: Luis Velasco/Getty Images Researchers at the University of Cambridge ...

A vaccine created using artificial intelligence that could potentially provide broader protection against multiple coronaviruses and help prepare for future outbreaks has passed its first human ...

A needle-free universal vaccine may soon be on the horizon. Scientists have successfully run the first trial, which showed the vaccine can safely elicit an immune response to several viruses. But more ...

You can listen to more articles from The Conversation, narrated by Noa, here. Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...

Stocks swooned on Friday after the Bureau of Labor Statistics reported that the economy created 172,000 jobs last month, driving interest rates higher and shifting sentiment firmly towards a rate hike ...

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe and well tolerated. The vaccine generated immune responses against ...

More and more routine vaccines are being linked to lower risks of dementia. Shots against seasonal flu, RSV, tetanus, diphtheria, and pertussis (Tdap), pneumococcal infections, hepatitis A and B, and ...

A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems, aiming to boost future protection and lower vaccine hesitancy rates. The study, led by Murdoch ...